StemPoint Capital LP
- SEC CIK
- 0001952142
- 最新申報
- 2026/8/14
2024 年第 1 季持倉
持倉截至 2024/3/31，2024/8/9 申報。只含多頭部位，變化是跟 2023 年第 4 季比股數。
- 持股檔數
- 45
- 較 2023 年第 4 季 −14
- 總值
- $3.74 億
- 較 2023 年第 4 季 +$316.4 萬 (+0.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| ROIVRoivant Sciences Ltd. | SHS | 3,553,844 | $3,746 萬 | 10.0% | +1,384,728+63.8% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 619,789 | $2,901 萬 | 7.8% | +370,214+148.3% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,100,988 | $2,620 萬 | 7.0% | +6,494+0.6% | 加碼 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 2,205,899 | $2,186 萬 | 5.8% | −388,637−15.0% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 627,228 | $2,027 萬 | 5.4% | +305,213+94.8% | 加碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 2,965,721 | $1,892 萬 | 5.1% | +2,514,346+557.0% | 加碼 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 1,547,141 | $1,823 萬 | 4.9% | +684,326+79.3% | 加碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 1,003,916 | $1,713 萬 | 4.6% | +553,210+122.7% | 加碼 | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,161,060 | $1,377 萬 | 3.7% | +737,886+174.4% | 加碼 | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 2,017,016 | $1,372 萬 | 3.7% | +1,109,864+122.3% | 加碼 | 歷史 |
| LLYEli Lilly & Co | Stock | 15,067 | $1,172 萬 | 3.1% | 00.0% | 不變 | 歷史 |
| MRUSMerus N.V. | COM | 233,871 | $1,053 萬 | 2.8% | −267,935−53.4% | 減碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 140,267 | $975.6 萬 | 2.6% | −173,337−55.3% | 減碼 | 歷史 |
| VTGNVistagen Therapeutics, Inc. | COM | 1,848,582 | $929.2 萬 | 2.5% | +58,400+3.3% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 222,253 | $807.9 萬 | 2.2% | +191,263+617.2% | 加碼 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,794,195 | $764.3 萬 | 2.0% | +1,794,195 | 新進 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 272,448 | $739.2 萬 | 2.0% | +98,869+57.0% | 加碼 | 歷史 |
| TRMLTourmaline Bio, Inc. | COM | 274,219 | $628.0 萬 | 1.7% | +274,219 | 新進 | 歷史 |
| ANABAnaptysbio, Inc | COM | 269,548 | $607.0 萬 | 1.6% | +224,548+499.0% | 加碼 | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 740,877 | $562.3 萬 | 1.5% | −42,295−5.4% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 491,926 | $517.0 萬 | 1.4% | −528,288−51.8% | 減碼 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 115,833 | $495.8 萬 | 1.3% | +115,833 | 新進 | 歷史 |
| SLRNACELYRIN, Inc. | COM | 714,773 | $482.5 萬 | 1.3% | +127,400+21.7% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 121,642 | $458.0 萬 | 1.2% | +121,642 | 新進 | 歷史 |
| BHVNBiohaven Ltd. | COM | 83,461 | $456.4 萬 | 1.2% | −27,893−25.0% | 減碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 90,647 | $455.3 萬 | 1.2% | −77,204−46.0% | 減碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 605,117 | $433.9 萬 | 1.2% | −1,983−0.3% | 減碼 | 歷史 |
| FULCFulcrum Therapeutics, Inc. | COM | 407,108 | $384.3 萬 | 1.0% | +30,535+8.1% | 加碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 87,393 | $383.5 萬 | 1.0% | +87,393 | 新進 | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 129,211 | $379.4 萬 | 1.0% | +129,211 | 新進 | 歷史 |
| AVDLAvadel Pharmaceuticals PLC | Stock | 223,660 | $377.8 萬 | 1.0% | +223,660 | 新進 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 60,129 | $374.4 萬 | 1.0% | −65,300−52.1% | 減碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,087,785 | $312.2 萬 | 0.8% | +1,087,785 | 新進 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 230,273 | $267.7 萬 | 0.7% | −626,679−73.1% | 減碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 62,253 | $236.1 萬 | 0.6% | −316,513−83.6% | 減碼 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 200,000 | $208.0 萬 | 0.6% | +200,000 | 新進 | 歷史 |
| EFTReFFECTOR Therapeutics, Inc. | COM NEW | 132,793 | $191.1 萬 | 0.5% | +132,793 | 新進 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 80,334 | $190.0 萬 | 0.5% | +80,334 | 新進 | 歷史 |
| CGONCG Oncology, Inc. | COM | 40,723 | $178.8 萬 | 0.5% | +40,723 | 新進 | 歷史 |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,385,750 | $173.2 萬 | 0.5% | +1,385,750 | 新進 | – |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 26,893 | $164.1 萬 | 0.4% | +26,893 | 新進 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 43,456 | $130.4 萬 | 0.3% | +43,456 | 新進 | 歷史 |
| CRGXCARGO Therapeutics, Inc. | COM | 51,126 | $114.1 萬 | 0.3% | +24,251+90.2% | 加碼 | 歷史 |
| KYTXKyverna Therapeutics, Inc. | COM | 41,000 | $101.8 萬 | 0.3% | +41,000 | 新進 | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 168,442 | $67.5 萬 | 0.2% | +168,442 | 新進 | 歷史 |
選擇權（17 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| CABACabaletta Bio, Inc. | COM | $107.5 萬 | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | $87.6 萬 | – |
| ARQTArcutis Biotherapeutics, Inc. | COM | $51.6 萬 | – |
| IMVTImmunovant, Inc. | COM | – | $31.9 萬 |
| MRUSMerus N.V. | COM | $21.3 萬 | – |
| Avidity Biosciences, Inc.05370A108 | COM | – | $18.4 萬 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | $15.8 萬 | – |
| ACLXArcellx, Inc. | COMMON STOCK | $13.5 萬 | – |
| BHVNBiohaven Ltd. | COM | $12.2 萬 | – |
| FOLDAmicus Therapeutics, Inc. | COM | – | $12.0 萬 |
| VERAVera Therapeutics, Inc. | CL A | $7.50 萬 | – |
| KRYSKrystal Biotech, Inc. | COM | $7.10 萬 | – |
| AUTLAutolus Therapeutics plc | SPON ADS | – | $6.88 萬 |
| ROIVRoivant Sciences Ltd. | SHS | $5.63 萬 | – |
| TARSTarsus Pharmaceuticals, Inc. | COM | $4.13 萬 | – |
| TARAProtara Therapeutics, Inc. | COM STK | – | $1.32 萬 |
| UTHRUnited Therapeutics Corp | COM | – | $1.07 萬 |
2023 年第 4 季之後清倉（31 檔）
2023 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 4 季股數 | 2023 年第 4 季市值 | 2023 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| PTGXProtagonist Therapeutics, Inc | COM | 513,681 | $1,178 萬 | 3.2% | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 253,948 | $1,025 萬 | 2.8% | 歷史 |
| Argenx SE04016X901 | CALL | 26,484 | $1,008 萬 | 2.7% | – |
| MRKMerck & Co., Inc. | Stock | 89,016 | $970.5 萬 | 2.6% | 歷史 |
| JNJJohnson & Johnson | Stock | 61,011 | $956.3 萬 | 2.6% | 歷史 |
| Teva Pharmaceutical Inds Ltd881624909 | CALL | 701,597 | $732.5 萬 | 2.0% | – |
| LNTHLantheus Holdings, Inc. | Stock | 108,911 | $675.2 萬 | 1.8% | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 104,650 | $629.7 萬 | 1.7% | 歷史 |
| SAGESage Therapeutics, Inc. | COM | 218,319 | $473.1 萬 | 1.3% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 20,444 | $473.0 萬 | 1.3% | 歷史 |
| SPYSPDR S&P 500 ETF Trust | ETF | 9,921 | $471.6 萬 | 1.3% | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 85,382 | $470.8 萬 | 1.3% | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 246,178 | $469.2 萬 | 1.3% | 歷史 |
| ETNB89bio, Inc. | COM | 408,257 | $456.0 萬 | 1.2% | 歷史 |
| CBAYCymaBay Therapeutics, Inc. | COM | 182,258 | $430.5 萬 | 1.2% | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 281,287 | $394.6 萬 | 1.1% | 歷史 |
| SCPHscPharmaceuticals Inc. | COM | 567,211 | $355.6 萬 | 1.0% | 歷史 |
| FATEFate Therapeutics Inc | COM | 898,196 | $335.9 萬 | 0.9% | 歷史 |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 183,102 | $321.2 萬 | 0.9% | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 22,500 | $296.5 萬 | 0.8% | 歷史 |
| Jasper Therapeutics Inc471871903 | CALL | 3,707,110 | $292.5 萬 | 0.8% | – |
| Morphosys AG617760902 | CALL | 277,485 | $274.7 萬 | 0.7% | – |
| EYPTEyePoint, Inc. | COM NEW | 95,732 | $221.2 萬 | 0.6% | 歷史 |
| ACIUAC Immune SA | SHS | 434,588 | $217.3 萬 | 0.6% | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 24,111 | $201.3 萬 | 0.5% | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 59,038 | $180.7 萬 | 0.5% | 歷史 |
| AMAMAmbrx Biopharma, Inc. | COM | 126,101 | $179.6 萬 | 0.5% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 58,450 | $145.2 萬 | 0.4% | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 279,648 | $124.7 萬 | 0.3% | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 83,381 | $122.7 萬 | 0.3% | 歷史 |
| STTKShattuck Labs, Inc. | COM | 147,752 | $105.3 萬 | 0.3% | 歷史 |